C. Lindberg

发表

Prevalence of myotonic dystrophy type 1 in adults in western Sweden

C. Lindberg, Fredrik Bjerkne, 2017, Neuromuscular Disorders.

Facial emotion recognition in myotonic dystrophy type 1 correlates with CTG repeat expansion

P. Hellström, S. Hansen, P. Hellström, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1

S. Dimauro, N. Romero, A. Engel, 2013, Annals of neurology.

Raised troponin T in inclusion body myositis is common and serum levels are persistent over time

A. Oldfors, C. Lindberg, L. Klintberg, 2006, Neuromuscular Disorders.

Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing

M. Falkenberg, S. Basu, K. Visuttijai, 2020, Brain pathology.

Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies

A. Tarkowski, A. Oldfors, C. Lindberg, 1994, European journal of immunology.

Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease

G. Bassez, J. Puymirat, H. Lochmüller, 2018, Orphanet Journal of Rare Diseases.

Myosin storage myopathy associated with a heterozygous missense mutation in MYH7

L. Thornell, B. Lindvall, K. Henriksson, 2003, Annals of neurology.

Glycogenin-1 deficiency and inactivated priming of glycogen synthesis.

B. Andersson, A. Oldfors, C. Lindberg, 2010, The New England journal of medicine.

A Sensitive Method for Detecting Peptide-specific CD4+ T Cell Responses in Peripheral Blood from Patients with Myasthenia Gravis

K. Schön, N. Lycke, S. Meisel, 2017, Front. Immunol..

Timing of diagnosis of patients with pompe disease: Data from the pompe registry

P. Kishnani, C. Lindberg, J. Keutzer, 2013, American journal of medical genetics. Part A.

Association between muscle strength, histopathology, and magnetic resonance imaging in sporadic inclusion body myositis

M. Geijer, A. Oldfors, C. Lindberg, 2018, Acta neurologica Scandinavica.

Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency

M. Roberts, E. Malfatti, A. Oldfors, 2021, Neuropathology and applied neurobiology.

Recessive myosin myopathy with external ophthalmoplegia associated with MYH2 mutations

L. Waddell, N. Clarke, N. Foulds, 2013, European Journal of Human Genetics.

Mitochondrial DNA Deletions in Muscle Fibers in Inclusion Body Myositis

E. Holme, N. Larsson, A. Oldfors, 1995, Journal of neuropathology and experimental neurology.

Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial

B. Byrne, A. Pestronk, M. Tarnopolsky, 2021, The Lancet Neurology.

Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy type 1 (DM1)

S. Hansen, C. Lindberg, S. Winblad, 2006, Behavioral and Brain Functions.

Loss of supervillin causes myopathy with myofibrillar disorganization and autophagic vacuoles

M. Geijer, H. Lochmüller, J. Weis, 2020, Brain : a journal of neurology.

Local T‐Cell Proliferation and Differentiation in Inflammatory Myopathies

A. Tarkowski, A. Oldfors, A. Tarkowski, 1995, Scandinavian journal of immunology.

Mitochondrial Myopathy and Rhabdomyolysis Associated with a Novel Nonsense Mutation in the Gene Encoding Cytochrome c Oxidase Subunit I

E. Holme, G. Kollberg, A. Oldfors, 2005, Journal of neuropathology and experimental neurology.

MELAS syndrome in a patient with a point mutation in MTTS1

A. Oldfors, C. Lindberg, A. Moslemi, 2007, Acta neurologica Scandinavica.

Methods of diagnosis of patients with Pompe disease: Data from the Pompe Registry.

P. Kishnani, C. Lindberg, J. Keutzer, 2012, Molecular genetics and metabolism.

Search for Pompe disease among patients with undetermined myopathies

A. Oldfors, M. Engvall, C. Lindberg, 2016, Acta neurologica Scandinavica.

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

Surgical treatment of obesity in DM1 – a case report and a review of the literature

C. Lindberg, K. Håkansson, S. Kostić, 2015, Neuromuscular Disorders.

Inclusion body myositis: morphological clues to correct diagnosis

A. Oldfors, C. Lindberg, K. Dahlbom, 2002, Neuromuscular Disorders.

Dominantly inherited myosin IIa myopathy caused by aberrant splicing of MYH2

M. Geijer, A. Oldfors, C. Lindberg, 2022, BMC Neurology.

Mitochondrial abnormalities in inclusion-body myositis

G. Kollberg, A. Oldfors, C. Lindberg, 2006, Neurology.

Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates

L. Samuelsson, J. Månsson, C. Lindberg, 2010, Behavioral and Brain Functions.

Congenital myopathy with nemaline rods and cap structures caused by a mutation in the beta-tropomyosin gene (TPM2).

A. Oldfors, C. Lindberg, H. Tajsharghi, 2007, Archives of neurology.

Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin.

B. Brådvik, B. Udd, C. Hedberg, 2012, Brain : a journal of neurology.

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

F. Piehl, A. Punga, A. Budzianowska, 2022, JAMA neurology.

Myopathy in a woman and her daughter associated with a novel splice site MTM1 mutation

G. Máthé, C. Hedberg, A. Oldfors, 2012, Neuromuscular Disorders.

A novel heteroplasmic point mutation in the mitochondrial tRNALys gene in a sporadic case of mitochondrial encephalomyopathy: De novo mutation and no transmission to the offspring

E. Holme, M. Houshmand, A. Oldfors, 1999, Human mutation.

Low frequency of mtDNA point mutations in patients with PEO associated with POLG1 mutations

E. Holme, Åsa Pérez-Bercoff, G. Kollberg, 2005, European Journal of Human Genetics.

Inclusion body myositis and welander distal myopathy: a clinical, neurophysiological and morphological comparison

A. Hedström, L. Edström, K. Borg, 1991, Journal of the Neurological Sciences.

Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases

A. Oldfors, C Lindberg, L I Persson, 1994, Acta Neurologica Scandinavica.

Quantification of mobility impairment and self-assessment of stiffness in patients with myotonia congenita by the physiotherapist

C. Lindberg, G. Kjellby-Wendt, E. Hammarén, 2005, Neuromuscular Disorders.

Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis

A. Oldfors, R. Pullerits, C. Lindberg, 2022, Annals of neurology.

Deep sequencing of mitochondrial DNA and characterization of a novel POLG mutation in a patient with arPEO

E. Larsson, M. Falkenberg, S. Basu, 2020, Neurology: Genetics.

Anti–T-lymphocyte globulin treatment in inclusion body myositis

A. Oldfors, A. Tarkowski, C Lindberg, 2003, Neurology.

Inclusion Body Myositis: Clonal Expansions of Muscle‐Infiltrating T Cells Persist Over Time

A. Oldfors, C Lindberg, A Oldfors, 2003, Scandinavian journal of immunology.

Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis

Christopher Lindberg, Andrej Tarkowski, A. Oldfors, 1997, Journal of Neuroimmunology.

Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?

O. Hammarsten, C. Lindberg, M. Svensson, 2021, Journal of Nephrology.

Reduced renal function in patients with Myotonic Dystrophy type 1 and the association to CTG expansion and other potential risk factors for chronic kidney disease

C. Lindberg, M. Svensson, A. Aldenbratt, 2017, Neuromuscular Disorders.

Inclusion body myositis.

A. Oldfors, C Lindberg, A Oldfors, 1999, Current opinion in neurology.

Diagnosis, pathogenesis and treatment of inclusion body myositis

Christopher Lindberg, A. Oldfors, Anders Oldfors, 2005, Current opinion in neurology.

Rituximab for severe myasthenia gravis – experience from five patients

M. Bokarewa, C. Lindberg, 2010, Acta neurologica Scandinavica.

Prognosis and prognostic factors in sporadic inclusion body myositis

A. Oldfors, C. Lindberg, Anders Oldfors, 2012, Acta neurologica Scandinavica.

Expression of Bcl‐2 in inclusion body myositis

A. Oldfors, C. Lindberg, I. Fyhr, 2002, Acta neurologica Scandinavica.

Episodes of exercise‐induced dark urine and myalgia in LGMD 2I

A. Oldfors, C. Lindberg, C. Sixt, 2012, Acta neurologica Scandinavica.

Progressive external ophthalmoplegia associated with novel MT‐TN mutations

K. Visuttijai, A. Oldfors, C. Lindberg, 2020, Acta neurologica Scandinavica.

Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations

Hanns Lochmüller, U. Schara, N. Barišić, 2009, Neuromuscular Disorders.

Improvements in health status and utility associated with ataluren for the treatment of nonsense mutation Duchenne muscular dystrophy

T. Sejersen, E. Landfeldt, C. Lindberg, 2019, Muscle & nerve.

Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy

N. Darín, E. Holmberg, M. Tulinius, 2006, Neuromuscular Disorders.

Skeletal muscle metabolism during prolonged exercise in Pompe disease

P. Laforêt, J. Vissing, H. Galbo, 2017, Endocrine connections.

Subnormal levels of POLγA cause inefficient initiation of light-strand DNA synthesis and lead to mitochondrial DNA deletions and progressive external ophthalmoplegia [corrected].

E. Holme, M. Falkenberg, A. Oldfors, 2013, Human molecular genetics.

Subnormal levels of POL g A cause inefﬁcient initiation of light-strand DNA synthesis and lead to mitochondrial DNA deletions and autosomal dominant progressive external ophthalmoplegia

E. Holme, M. Falkenberg, A. Oldfors, 2013 .

Analysis of multiple mitochondrial DNA deletions in inclusion body myositis

A. Oldfors, C. Lindberg, A. Moslemi, 1997, Human mutation.

Temperament and character in patients with classical myotonic dystrophy type 1 (DM-1)

S. Hansen, C. Lindberg, S. Winblad, 2005, Neuromuscular Disorders.

PSYCHOLOGICAL FUNCTIONING IN WOMEN WITH FIBROMYALGIA: A GROUNDED THEORY STUDY

K. Wentz, L. Hallberg, C. Lindberg, 2004, Health care for women international.

Cerebral palsy and bruxism: Effects of botulinum toxin injections—A randomized controlled trial

C. Lindberg, L. Dahlström, B. J. Cahlin, 2019, Clinical and experimental dental research.

A SCA7 premutation may be a novel Mendelian modifier of MS course: A case report.

O. Andersen, C. Lindberg, M. Axelsson, 2019, Multiple sclerosis and related disorders.

Body composition in patients with primary neuromuscular disease assessed by dual energy X-ray absorptiometry (DXA) and three different bioimpedance devices.

L. Ellegård, C Lindberg, L Ellegård, 2019, Clinical nutrition ESPEN.

A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome

H. Lochmüller, V. Rakocevic-Stojanovic, J. Colomer, 2012, Journal of Neurology.

Modified Exercise Test in Screening for Mitochondrial Myopathies – Adjustment of Workload in Relation to Muscle Strength

M. Kreuter, C. Lindberg, Lena Rafsten, 2004, European Neurology.

Muscle force, balance and falls in muscular impaired individuals with myotonic dystrophy type 1: A five-year prospective cohort study

C. Lindberg, G. Kjellby-Wendt, E. Hammarén, 2015, Neuromuscular Disorders.

Factors of importance for dynamic balance impairment and frequency of falls in individuals with myotonic dystrophy type 1 – A cross-sectional study – Including reference values of Timed Up & Go, 10m walk and step test

J. Kowalski, C. Lindberg, G. Kjellby-Wendt, 2014, Neuromuscular Disorders.

Cognition in myotonic dystrophy type 1: a 5‐year follow‐up study

G. Meola, L. Samuelsson, C. Lindberg, 2016, European journal of neurology.

G.P.255 Epidemiology and screening of Pompe disease in Sweden

G. Solders, A. Sundström, C. Lindberg, 2014, Neuromuscular Disorders.

Inclusion body myositis: peripheral nerve involvement Combined morphological and electrophysiological studies on peripheral nerves

A. Hedström, A. Oldfors, C. Lindberg, 1990, Journal of the Neurological Sciences.

T cell receptor β-chain repertoire in inclusion body myositis

Christopher Lindberg, A. Oldfors, Anders Oldfors, 1998, Journal of Neuroimmunology.

Limited T‐Cell Receptor V Gene Usage in Inclusion Body Myositis

A. Oldfors, A. Tarkowski, C. Lindberg, 1996, Scandinavian journal of immunology.

Mitochondrial DNA deletions in inclusion body myositis.

E. Holme, N. Larsson, A. Oldfors, 1993, Brain : a journal of neurology.

Hand function in 45 patients with sporadic inclusion body myositis.

C. Lindberg, M. Eriksson, 2012, Occupational therapy international.

Phenotypic spectrum and clinical course of single large-scale mitochondrial DNA deletion disease in the paediatric population: a multicentre study

K. Majamaa, J. Vissing, N. Darín, 2021, Journal of Medical Genetics.

Reliability of static and dynamic balance tests in subjects with myotonic dystrophy type 1

C. Lindberg, G. Kjellby-Wendt, E. Hammarén, 2012 .

Cerebrospinal fluid tau and amyloid β42 protein in patients with myotonic dystrophy type 1

K. Blennow, L. Samuelsson, J. Månsson, 2008, European journal of neurology.

A novel mutation in the mitochondrial tRNAPhe gene associated with mitochondrial myopathy

E. Holme, G. Kollberg, A. Oldfors, 2004, Neuromuscular Disorders.

Researchin Myotonic Dystrophy type 1: clinical and neuronal correlates

L. Samuelsson, J. Månsson, C. Lindberg, 2010 .

Mitochondrial pathology in inclusion body myositis

A. Oldfors, C. Lindberg, A. Moslemi, 2015, Neuromuscular Disorders.

Renal Phenotype in Mitochondrial Diseases: A Multicenter Study

I. D. de Coo, E. Ostergaard, N. Darín, 2022, Kidney Diseases.

Carey-Fineman-Ziter syndrome with mutations in the myomaker gene and muscle fiber hypertrophy

A. Oldfors, C. Lindberg, C. Hedberg-Oldfors, 2018, Neurology: Genetics.

Perceived fatigue in myotonic dystrophy type 1: a case-control study

C. Lindberg, S. Winblad, 2019, BMC Neurology.

On parole: The natural history of recovery from fibromyalgia in women: A grounded theory study

K. Wentz, C. Lindberg, 2012 .

Remission rate after thymectomy in myasthenia gravis when the bias of immunosuppressive therapy is eliminated

S. Larsson, A. Odén, C. Lindberg, 1992, Acta neurologica Scandinavica.

Late-onset spinal motor neuronopathy – A common form of dominant SMA

B. Udd, C. Lindberg, S. Penttilä, 2014, Neuromuscular Disorders.

Facial memory deficits in myotonic dystrophy type 1

C. Lindberg, S. Winblad, J.L. Kleberg, 2014, Acta neurologica Scandinavica.

Expression pattern of mitochondrial respiratory chain enzymes in skeletal muscle of patients with mitochondrial myopathy associated with the homoplasmic m.14674T>C variant

N. Darín, K. Visuttijai, G. Kollberg, 2021, Brain pathology.

Inclusion body myositis with early onset: a population-based study

A. Oldfors, R. Pullerits, C. Lindberg, 2023, Journal of Neurology.

Behavioral and Brain Functions

S. Hansen, P. Yang, C. Lindberg, 2006 .

Muscle force, balance and falls in muscular impaired individuals with myotonic dystrophy type 1: A five-year prospective cohort study

C. Lindberg, G. Kjellby-Wendt, E. Hammarén, 2015, Neuromuscular Disorders.

Association between muscle strength, histopathology, and magnetic resonance imaging in sporadic inclusion body myositis

M. Geijer, A. Oldfors, C. Lindberg, 2018, Acta neurologica Scandinavica.

Effects of a balance exercise programme in myotonic dystrophy type 1: A pilot study

C. Lindberg, G. Kjellby-Wendt, E. Hammarén, 2015 .

J. Kowalski, C. Lindberg, G. Kjellby-Wendt, 2014, Neuromuscular Disorders.